Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03855787 · ClinicalTrials.gov registry record · NA
Ureteral Stent Placement After Ureteroscopy for Renal Stones: A Randomized Controlled Trial
A NA study of Kidney Calculi, sponsored by Vanderbilt University Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 103
- Enrollment target
- 7
- Study locations
NCT03855787 is a NA study of Kidney Calculi that has completed, run by Vanderbilt University Medical Center. The registered enrollment target is 103 participants, below the 134-participant average among 7 other Kidney Calculi trials with a reported enrollment target (23% lower). The trial reports 7 study locations across 5 states.
The verdict
NCT03855787, a NA study of Kidney Calculi, has completed, sponsored by Vanderbilt University Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 103 participants
- Enrollment target
- 7
- Study locations
Study Summary
The rationale for this study is to determine if there is a difference in complications among patients undergoing ureteroscopy for renal stones who receive a stent compared to not receiving a stent postoperatively.
Conditions Studied
Interventions
- PROCEDURE Ureteroscopy
Study Locations (7)
California
- University of California Los Angeles - Los Angeles
- University of California Davis - Sacramento
- University of California San Diego - San Diego
Indiana
- Indiana University Health Physicians Urology - Indianapolis
Massachusetts
- Brigham and Women's Hospital - Boston
Tennessee
- Vanderbilt University Medical Center - Nashville
Other
- University of Montreal - Montreal
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 103 participants |
| Start Date | 2019-11-11 |
| Est. Completion | 2025-01-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03855787
The ClinicalTrials.gov registry entry for NCT03855787 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 103 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 134-participant average among 7 other Kidney Calculi trials with a reported enrollment target (23% lower). The listed sponsor is Vanderbilt University Medical Center, which has 677 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Kidney Calculi appearing as the primary indexed condition, and to 1 intervention - of which Ureteroscopy is the first listed.
NCT03855787 reports 7 study locations spanning 5 distinct geographic areas - top geographies include California, Indiana, Massachusetts.
Frequently Asked Questions
What is clinical trial NCT03855787 about?
NCT03855787 is a clinical study titled "Ureteral Stent Placement After Ureteroscopy for Renal Stones: A Randomized Controlled Trial". The rationale for this study is to determine if there is a difference in complications among patients undergoing ureteroscopy for renal stones who receive a stent compared to not receiving a stent postoperatively.
What is the current status of trial NCT03855787?
This trial is currently completed. It is a NA study. The enrollment target is 103 participants. The study started on 2019-11-11. Estimated completion is 2025-01-01.
What conditions does trial NCT03855787 study?
This clinical trial studies the following conditions: Kidney Calculi.
What interventions are being tested in trial NCT03855787?
The interventions under investigation include: Ureteroscopy (PROCEDURE).
Who is sponsoring clinical trial NCT03855787?
This trial is sponsored by Vanderbilt University Medical Center, which has 677 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03855787 being conducted?
This trial has 7 study locations across California, Indiana, Massachusetts, Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Kidney Calculi
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Endogenous Oxalate Synthesis in Idiopathic Calcium Oxalate Kidney Stone Disease
RECRUITING · NA
-
Methocarbamol vs Oxybutynin for Management of Pain and Discomfort S/P Ureteroscopy Procedure
RECRUITING · NA
-
Gut Oxalate Absorption in Calcium Oxalate Stone Disease
RECRUITING · NA
-
O. Formigenes Colonization in Calcium Oxalate Kidney Stone Disease
RECRUITING · NA
-
SOUND Pivotal Trial - (Sonomotion stOne comminUtion resoNance ultrasounD)
ACTIVE NOT RECRUITING · NA
-
Standard vs Mini-PCNL for the Treatment of Stone Disease
COMPLETED · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.